WallStSmart

Colgate-Palmolive Company (CL)vsInter Parfums Inc (IPAR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 1302% more annual revenue ($21.05B vs $1.50B). IPAR leads profitability with a 11.2% profit margin vs 9.7%. CL appears more attractively valued with a PEG of 1.60. CL earns a higher WallStSmart Score of 54/100 (C-).

CL

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21

IPAR

Hold

46

out of 100

Grade: D+

Growth: 4.7Profit: 7.0Value: 3.3Quality: 8.5
Piotroski: 2/9Altman Z: 4.14
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+12.6%)

Margin of Safety

+12.6%

Fair Value

$99.34

Current Price

$86.80

$12.54 discount

UndervaluedFair: $99.34Overvalued
IPARSignificantly Overvalued (-33.3%)

Margin of Safety

-33.3%

Fair Value

$75.50

Current Price

$112.01

$36.51 premium

UndervaluedFair: $75.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
863.1%10/10

Every $100 of equity generates 863 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$69.19B9/10

Large-cap with strong market position

Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

IPAR2 strengths · Avg: 9.5/10
Altman Z-ScoreHealth
4.1410/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Areas to Watch

CL4 concerns · Avg: 3.5/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

P/E RatioValuation
34.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
4.9%4/10

4.9% revenue growth

Price/BookValuation
289.3x2/10

Trading at 289.3x book value

IPAR4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.1%4/10

2.1% revenue growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
3.202/10

Expensive relative to growth rate

EPS GrowthGrowth
-4.0%2/10

Earnings declined 4.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bull Case : IPAR

The strongest argument for IPAR centers on Altman Z-Score, Debt/Equity.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Revenue Growth. Debt-to-equity of 33.29 is elevated, increasing financial risk.

Bear Case : IPAR

The primary concerns for IPAR are Revenue Growth, Piotroski F-Score, PEG Ratio.

Key Dynamics to Monitor

IPAR carries more volatility with a beta of 1.13 — expect wider price swings.

CL is growing revenue faster at 4.9% — sustainability is the question.

CL generates stronger free cash flow (867M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CL scores higher overall (54/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Inter Parfums Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Inter Parfums, Inc., manufactures, markets and distributes a range of fragrances and fragrance-related products in the United States and internationally. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?